Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lumos Diagnostics Holdings Ltd. has announced a non-renounceable entitlement offer to raise A$10 million by offering new shares at a 17.4% discount to current shareholders, aiming to fund clinical trials, product development, and general working capital. The offer, lead-managed by Bell Potter Securities Limited, allows shareholders to maintain their ownership percentage and avoid dilution, but non-participating shareholders won’t receive value for unclaimed entitlements.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- Intel Stock (NASDAQ:INTC) Slips Despite Growing Interest in AI
- “…Tied to the Effort From the Administration” Boeing Stock (NYSE:BA) Blasts Up as Boeing Counts on New Top Sales Rep in China: President Trump
- “We Do Not Have Conflicting Interests….” Microsoft Stock (NASDAQ:MSFT) Gains on New Plan to be the Agentic AI Internet’s Backbone